Abivax SA (ABVX)
83.83
+1.73
(+2.11%)
USD |
NASDAQ |
Nov 18, 16:00
84.00
+0.17
(+0.20%)
After-Hours: 20:00
Abivax Price to Book Value : 15.98 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 15.98 |
| November 17, 2026 | 15.65 |
| November 16, 2026 | 15.94 |
| November 13, 2026 | 16.69 |
| November 12, 2026 | 17.19 |
| November 11, 2026 | 17.43 |
| November 10, 2026 | 17.15 |
| November 09, 2026 | 16.58 |
| November 06, 2026 | 16.34 |
| November 05, 2026 | 16.04 |
| November 04, 2026 | 17.06 |
| November 03, 2026 | 16.91 |
| November 02, 2026 | 16.18 |
| October 30, 2026 | 16.50 |
| October 29, 2026 | 16.98 |
| October 28, 2026 | 17.12 |
| October 27, 2026 | 16.58 |
| October 26, 2026 | 16.49 |
| October 23, 2026 | 16.78 |
| October 22, 2026 | 17.20 |
| October 21, 2026 | 17.82 |
| October 20, 2026 | 17.65 |
| October 19, 2026 | 16.68 |
| October 16, 2026 | 16.80 |
| October 15, 2026 | 17.61 |
| Date | Value |
|---|---|
| October 14, 2026 | 16.77 |
| October 13, 2026 | 16.43 |
| October 12, 2026 | 16.57 |
| October 09, 2026 | 16.80 |
| October 08, 2026 | 16.97 |
| October 07, 2026 | 16.58 |
| October 06, 2026 | 16.82 |
| October 05, 2026 | 17.48 |
| October 02, 2026 | 17.70 |
| October 01, 2026 | 18.13 |
| September 30, 2026 | 18.87 |
| September 29, 2026 | 18.77 |
| September 28, 2026 | 18.46 |
| September 25, 2026 | 17.36 |
| September 24, 2026 | 18.08 |
| September 23, 2026 | 17.94 |
| September 22, 2026 | 18.73 |
| September 21, 2026 | 19.72 |
| September 18, 2026 | 20.02 |
| September 17, 2026 | 20.39 |
| September 16, 2026 | 19.49 |
| September 15, 2026 | 20.33 |
| September 14, 2026 | 21.65 |
| September 11, 2026 | 22.61 |
| September 10, 2026 | 22.10 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 7.036 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.8624 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0545 |
| Price | 83.83 |
| Earnings Yield | -7.28% |
| Market Cap | 6.691B |
| PEGY Ratio | -0.0545 |